{"id":641879,"date":"2013-02-08T07:53:23","date_gmt":"2013-02-08T12:53:23","guid":{"rendered":"http:\/\/www.pehub.com\/?p=185588"},"modified":"2013-02-08T07:53:23","modified_gmt":"2013-02-08T12:53:23","slug":"reuters-3sbio-to-go-private-in-340m-deal","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/641879","title":{"rendered":"Reuters \u2013 3SBio to Go Private in $340M Deal"},"content":{"rendered":"<p>Chinese biotechnology firm <strong>3SBio Inc.<\/strong> said it agreed to be bought by <strong>Decade Sunshine Ltd.<\/strong> for about $340 million, <em>Reuters<\/em> reported. The offer of $15.40 per American Depositary Shares is at a premium of about 12 percent to the ADS&#8217;s Thursday close of $13.79.<\/p>\n<p>(<em>Reuters<\/em>) &#8211; Chinese biotechnology firm 3SBio Inc said it agreed to be bought by Decade Sunshine Ltd for about $340 million.<\/p>\n<p>The offer of $15.40 per American Depositary Shares (ADS) is at a premium of about 12 percent to the ADS&#8217;s Thursday close of $13.79.<\/p>\n<p>3SBio Chief Executive Jing Lou had offered to take the company private for up to $15 per ADS, or about $331 million, last September.<\/p>\n<p>The post <a href=\"http:\/\/www.pehub.com\/185588\/reuters-3sbio-go-private-340m-deal\/\">Reuters &#8211; 3SBio to Go Private in $340M Deal<\/a> appeared first on <a href=\"http:\/\/www.pehub.com\/\">peHUB<\/a>.<\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=aw0AFAP037g:LOouJIkH4qg:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=aw0AFAP037g:LOouJIkH4qg:dnMXMwOfBR0\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=dnMXMwOfBR0\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=aw0AFAP037g:LOouJIkH4qg:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=aw0AFAP037g:LOouJIkH4qg:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=aw0AFAP037g:LOouJIkH4qg:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=7Q72WNTAKBA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=aw0AFAP037g:LOouJIkH4qg:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=aw0AFAP037g:LOouJIkH4qg:V_sGLiPBpWU\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=aw0AFAP037g:LOouJIkH4qg:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=qj6IDK7rITs\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=aw0AFAP037g:LOouJIkH4qg:l6gmwiTKsz0\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=l6gmwiTKsz0\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/pehub\/news\/all\/~4\/aw0AFAP037g\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chinese biotechnology firm 3SBio Inc. said it agreed to be bought by Decade Sunshine Ltd. for about $340 million, Reuters reported. The offer of $15.40 per American Depositary Shares is at a premium of about 12 percent to the ADS&#8217;s Thursday close of $13.79. (Reuters) &#8211; Chinese biotechnology firm 3SBio Inc said it agreed to [&hellip;]<\/p>\n","protected":false},"author":7428,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-641879","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/641879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/7428"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=641879"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/641879\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=641879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=641879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=641879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}